Business Description
Vicore Pharma Holding AB
ISIN : SE0007577895
Compare
Compare
Traded in other countries / regions
VICO.Sweden6Y4.Germany IPO Date
2015-12-10Description
Vicore Pharma Holding AB is as a clinical-stage pharmaceutical company focused on severe lung diseases. The company is establishing a portfolio in respiratory diseases, including idiopathic pulmonary fibrosis (IPF). Its C21 is a small molecule angiotensin II type 2 receptor agonist (ATRAG) currently in phase 2a development for IPF. The company also has an investigational medical device in clinical development namely, Almee which is a digital therapeutic leveraging cognitive behavioral therapy created to address the psychological impact of living with pulmonary fibrosis.
Financial Strength
7/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| Cash-To-Debt | No Debt | |||||
| Equity-to-Asset | 0.92 | |||||
| Piotroski F-Score | 3/9 | |||||
| WACC vs ROIC | ||||||
Growth Rank
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| 3-Year EBITDA Growth Rate | -6.4 | |||||
| 3-Year EPS without NRI Growth Rate | -5.9 | |||||
| 3-Year FCF Growth Rate | -4.5 | |||||
| 3-Year Book Growth Rate | -11.4 |
Momentum Rank
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| 5-Day RSI | 59.03 | |||||
| 9-Day RSI | 57.35 | |||||
| 14-Day RSI | 57.53 | |||||
| 6-1 Month Momentum % | 8.15 | |||||
| 12-1 Month Momentum % | -17.74 |
Liquidity Ratio
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| Current Ratio | 12.1 | |||||
| Quick Ratio | 12.1 | |||||
| Cash Ratio | 11.78 |
Dividend & Buy Back
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| 3-Year Average Share Buyback Ratio | -22.7 | |||||
| Shareholder Yield % | -27.44 |
Profitability Rank
1/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| ROE % | -84.6 | |||||
| ROA % | -75.73 | |||||
| ROIC % | -439.83 | |||||
| ROC (Joel Greenblatt) % | -790162.44 | |||||
| ROCE % | -84.19 | |||||
| Years of Profitability over Past 10-Year | 1 |
GF Value Rank
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| PB Ratio | 4.09 | |||||
| Price-to-Tangible-Book | 4.23 | |||||
| EV-to-EBIT | -5.33 | |||||
| EV-to-Forward-EBIT | -4.75 | |||||
| EV-to-EBITDA | -5.33 | |||||
| EV-to-Forward-EBITDA | -4.75 | |||||
| EV-to-FCF | -6.27 | |||||
| Price-to-Net-Current-Asset-Value | 4.23 | |||||
| Price-to-Net-Cash | 4.36 | |||||
| Earnings Yield (Greenblatt) % | -18.77 | |||||
| FCF Yield % | -13 |
Historical Operating Revenue by Business Segment
Historical Operating Revenue by Geographic Region
Guru Trades
See DetailsInsider Trades
See DetailsPeter Lynch Chart
Performance
Dividend
Log
Bar
Annualized Return % Â
Total Annual Return % Â
Vicore Pharma Holding AB Executives
DetailsAnalyst Estimate
Key Statistics
| Name | Value | ||
|---|---|---|---|
| Revenue (TTM) (Mil kr) | |||
| EPS (TTM) (kr) | -3.28 | ||
| Beta | 0 | ||
| Volatility % | 32.04 | ||
| 14-Day RSI | 57.53 | ||
| 14-Day ATR (kr) | 0.904602 | ||
| 20-Day SMA (kr) | 16.641 | ||
| 12-1 Month Momentum % | -17.74 | ||
| 52-Week Range (kr) | 12.36 - 26.9 | ||
| Shares Outstanding (Mil) | 111.72 |
Piotroski F-Score Details
Year:
| Component | Result | ||
|---|---|---|---|
| Piotroski F-Score | 3 | ||
| Positive ROA | |||
| Positive CFROA | |||
| Higher ROA yoy | |||
| CFROA > ROA | |||
| Lower Leverage yoy | |||
| Higher Current Ratio yoy | |||
| Less Shares Outstanding yoy | |||
| Higher Gross Margin yoy | |||
| Higher Asset Turnover yoy |
Vicore Pharma Holding AB Filings
| Filing Date | Document Date | Form | ||
|---|---|---|---|---|
| No Filing Data | ||||
Vicore Pharma Holding AB Stock Events
| Event | Date | Price(kr) | ||
|---|---|---|---|---|
| No Event Data | ||||
Vicore Pharma Holding AB Frequently Asked Questions
What is Vicore Pharma Holding AB(OSTO:VICO)'s stock price today?
The current price of OSTO:VICO is kr17.18. The 52 week high of OSTO:VICO is kr26.90 and 52 week low is kr12.36.
When is next earnings date of Vicore Pharma Holding AB(OSTO:VICO)?
The next earnings date of Vicore Pharma Holding AB(OSTO:VICO) is 2024-05-03.
Does Vicore Pharma Holding AB(OSTO:VICO) pay dividends? If so, how much?
Vicore Pharma Holding AB(OSTO:VICO) does not pay dividend.
Press Release
| Subject | Date | |||
|---|---|---|---|---|
| No Press Release | ||||
Survey
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
Follow Us
Disclaimers